This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Mikaela Mohardt: Innovator in Cancer Treatment
Introduction
Mikaela Mohardt is a prominent inventor based in Brookline, MA (US). She has made significant contributions to the field of cancer research through her innovative work on small-molecule focal adhesion kinase (FAK) inhibitors. Her research focuses on developing compounds that can inhibit FAK activity, which is often aberrant in various cancer types.
Latest Patents
Mikaela holds 1 patent for her groundbreaking work. The patent details compounds that possess inhibitory activity against FAK. Additionally, it includes pharmaceutical compositions containing these compounds and methods for using them to treat cancers mediated by aberrant FAK activity.
Career Highlights
Mikaela is currently affiliated with the Dana-Farber Cancer Institute Inc., where she continues her research and development efforts. Her work is pivotal in advancing therapeutic options for cancer patients.
Collaborations
Mikaela collaborates with esteemed colleagues, including Nathanael S. Gray and David A. Scott. These partnerships enhance her research and contribute to the collective goal of improving cancer treatment.
Conclusion
Mikaela Mohardt is a dedicated inventor whose work on FAK inhibitors represents a significant advancement in cancer therapy. Her contributions are vital in the ongoing fight against cancer, and her innovative spirit continues to inspire progress in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile